NEPH Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$6.25median target· current $4.41 (+41.7%)3 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio25.50
EPS (TTM)$0.16450.0% YoY
Profit margin8.4%HEALTHCARE
Market cap$44.3MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- 0.00
- P/B
- 3.67
- P/S (TTM)
- 2.14
- EV/EBITDA
- 21.39
Profitability & growth
- ROE (TTM)
- 16.1%
- Operating margin
- 20.2%
- Revenue growth YoY
- 36.2%
- Dividend yield
- —
- Beta
- 1.52
Last earnings
Aug 6, 2026 · Estimate $0.01 · Reported $0.06
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Nephros Inc
Company profileNephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$44.3M
Shares outstanding$10.9M
52W high$6.42
52W low$2.66
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent